slaclab/lsst-ac-filter-relay
This is the repository for "lsst-ac-filter-relay" developed by SLAC National Accelerator Laboratory.
Engineering topics
Publications and source records attributed to Olsen, Jeff.
This is the repository for "lsst-ac-filter-relay" developed by SLAC National Accelerator Laboratory.
This is the repository for "LsstPsProdTop" developed by SLAC National Accelerator Laboratory.
This is the repository for "lsst-ion-pump-ps-controller" developed by SLAC National Accelerator Laboratory.
This is the repository for "lsst-dcpdu" developed by SLAC National Accelerator Laboratory.
This is the repository for "lcls-mr-llrf-interlock-rtm" developed by SLAC National Accelerator Laboratory.
Purpose: This work describes a commercial treatment planning system, its technical features, and its capabilities for creating {sup 60}Co intensity modulated radiation therapy (IMRT) treatment plans for a magnetic resonance image guidance radiation therapy (MR-IGRT) system. Methods and Materials: The ViewRay treatment planning system (Oakwood Village, OH) was used to create {sup 60}Co IMRT treatment plans for 33 cancer patients with disease in the abdominal, pelvic, thorax, and head and neck regions using physician-specified patient-specific target coverage and organ at risk (OAR) objectives. Backup plans using a third-party linear accelerator (linac)-based planning system were also created. Plans were evaluated by attending physicians and approved for treatment. The {sup 60}Co and linac plans were compared by evaluating conformity numbers (CN) with 100% and 95% of prescription reference doses and heterogeneity indices (HI) for planning target volumes (PTVs) and maximum, mean, and dose-volume histogram (DVH) values for OARs. Results: All {sup 60}Co IMRT plans achieved PTV coverage and OAR sparing that were similar to linac plans. PTV conformity for {sup 60}Co was within <1% and 3% of linac plans for 100% and 95% prescription reference isodoses, respectively, and heterogeneity was on average 4% greater. Comparisons of OAR mean dose showed generally better sparing with linac plans in the low-dose range <20 Gy, but comparable sparing for organs with mean doses >20 Gy. The mean doses for all {sup 60}Co plan OARs were within clinical tolerances. Conclusions: A commercial {sup 60}Co MR-IGRT device can produce highly conformal IMRT treatment plans similar in quality to linac IMRT for a variety of disease sites. Additional work is in progress to evaluate the clinical benefit of other novel features of this MR-IGRT system.
The SLAC P2 MARX Modulator consists of 32 cells charged in parallel by a -4 kV supply and discharged in series to provide a -120 kV 140 amp 1.7 millisecond pulse. Each cell has a 350 uF main storage capacitor. The voltage on the capacitor will droop approximately 640 volts during each pulse. Each cell will have a boost supply that can add up to 700 V to the cell output. This allows the output voltage of the cell to remain constant within 0.1% during the pulse. The modulator output voltage control is determined by the -4 kV charging voltage. A voltage divider will measure the modulator voltage on each pulse. The charging voltage will be adjusted by the data from previous pulses to provide the desired output. The boost supply in each cell consists of a 700 V buck regulator in series with the main capacitor. The supply uses a lookup table for PWM control. The lookup table is calculated from previous pulse data to provide a constant cell output. The paper will describe the modulator and cell regulation used by the MARX modulator. Measured data from a single cell and three cell string will be included.
This paper is a status update of the SLAC P2 Marx. This Marx-topology klystron modulator is a second-generation modulator which builds upon experience gained from the SLAC P1 Marx. There are several fundamental differences between these modulators including the correction scheme, bus voltages, and the control system architecture. These differences, along with preliminary experimental results and the schedule for further development, are detailed in this paper.
A Marx-topology klystron modulator is under development for the International Linear Collider (ILC) project. It is envisioned as a lower cost, smaller footprint, and higher reliability alternative to the present, bouncer-topology, baseline design. The application requires 120 kV (+/-0.5%), 140 A, 1.6 ms pulses at a rate of 5 Hz. The Marx constructs the high voltage pulse by combining, in series, a number of lower voltage cells. The Marx employs solid state elements; IGBTs and diodes, to control the charge, discharge and disolation of the cells. Active compensation of the output is used to achieve the voltage regulation while minimizing the stored energy. The developmental testing of a first generation prototype, P1, has been completed. This modulator has been integrated into a test stand with a 10 MW L-band klystron, where each is undergoing life testing. Development of a second generation prototype, P2, is underway. The P2 is based on the P1 topology but incorporates an alternative cell configuration to increase redundancy and improve availability. Status updates for both prototypes are presented.
The SLAC National Accelerator Laboratory is developing a second generation Marx-type modulator for the ILC, the P2-Marx. The modulator is expected to operate reliably in excess of 10{sup 5} hours with minimum downtime. A prognostic system is being implemented with the development of the P2-Marx to monitor and track the health of key high voltage components. This paper discusses the way in which the prognostic system will be implemented and used to monitor the health of the P2-Marx modulator.